Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Adjunctive doxorubicin in feline mammary gland tumors
Mammary gland tumors in cats are rare compared with other species e.g. dogs - but if they are diagnosed they tend to be highly malignant. The therapy of choice is surgical removal as soon as possible. Does doxorubicin improve the prognosis? A very interesting retrospective study...

Medical records for 67 cats with histologically confirmed mammary gland adenocarcinomas treated with adjunctive doxorubicin from June 1994 through December 2002 were reviewed.

Data were examined to evaluate factors influencing disease-free interval (DFI) and survival time.

The Kaplan-Meier median survival time of cats that received surgery and doxorubicin was 448 days.

The Kaplan-Meier median DFI was 255 days.

Significant univariate prognostic factors for DFI included histological subtype, completion of initial chemotherapy, development of metastatic disease, and location of metastatic disease.

Significant univariate prognostic factors for survival included tumor volume, the development of metastatic disease, and location of metastatic disease.




Source: C. Andrew Novosad et al (2006): Retrospective Evaluation of Adjunctive Doxorubicin for the Treatment of Feline Mammary Gland Adenocarcinoma: 67 Cases. In: Journal of the American Animal Hospital Association 42:110-120 (2006)



Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Oral extended release hydrocodone as analgesia after TPLOmembers
Tibial plateau leveling osteotomy (TPLO) is a very popular technique to treat ruptured cranial cruciate ligaments in dogs, and it requires a balanced analgesia regimen after surgery. The aim of this study was to determine the efficacy of oral extended‐release hydrocodone compared with oral firocoxib for analgesia following tibial plateau leveling osteotomy surgery in dogs in a hospital setting.

  • 25OH vitamin D3 serum concentration in dogs with acute polyradiculoneuritismembers
  • Type 1 immune mediated polyarthritis in dogs and temporal relationship to vaccination members
  • Phosphorus and protein supply before diagnosis of chronic kidney disease members
  • Bilateral retinoschisis in a Labrador retrievermembers
  • Water requirements of canine athletes during exercise over daysmembers
  • Predictors of Sudden Cardiac Death in Doberman Pinschers with DCMmembers
  • D-dimer concentration after soft tissue and orthopedic surgery members
  • Canine oral mucosa as autograft in unresponsive keratoconjunctivitis siccamembers
  • Computed tomographic findings in dogs infected with Crenosoma vulpismembers
  • Predicting histopathological classification of canine mammary carcinomas via sonographymembers
  • The expression of Vitamin D receptors in dogsmembers
  • Complex atlanto-axial malformation in a rabbitmembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved